Precigen (PGEN) Retained Earnings (2012 - 2026)
Precigen (PGEN) posted quarterly Retained Earnings of -$17000.0 for Q1 2026, up 100.0% year-over-year from -$8500.0 in Q1 2025, and down 100.0% quarter-over-quarter from $2.4 billion in Q4 2025.
Precigen (PGEN) Retained Earnings (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Retained Earnings for 15 consecutive years, with -$17000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings rose 100.0% year-over-year to -$17000.0; the TTM figure through Mar 2026 stood at -$17000.0 (up 100.0% YoY), while the FY2025 annual figure was $2.4 billion, up 19685333.33% from the prior year.
- Retained Earnings slipped to -$17000.0 in Q1 2026 per PGEN's latest filing, from $2.4 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $2.4 billion in Q4 2025 and bottomed at -$2.1 billion in Q1 2025.
- Historically, Retained Earnings has averaged $410.3 million across 5 years, with a median of -$17000.0 in 2026.
- Annual changes were most pronounced in 2024 — Retained Earnings slumped 73564.65% — and 2025, when it jumped 19685333.33%.
- Precigen's Retained Earnings stood at -$3.5 million in 2022, then surged by 59873.97% to $2.1 billion in 2023, then tumbled by 100.0% to $12000.0 in 2024, then surged by 19685333.33% to $2.4 billion in 2025, then plunged by 100.0% to -$17000.0 in 2026.
- Business Quant data shows PGEN's Retained Earnings at -$17000.0 in Q1 2026, $2.4 billion in Q4 2025, and $2.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Precigen | 2.18 Bn | 2.18 Bn | 52.17 Mn | 2.37 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.37 Bn |
| Mar 31, 2026 | -17,000.00 |
| Dec 31, 2025 | 2.36 Bn |
| Sep 30, 2025 | 2.36 Bn |
| Jun 30, 2025 | 2.13 Bn |
| Mar 31, 2025 | -2.14 Bn |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | -2.07 Bn |
| Jun 30, 2024 | 2.09 Bn |
| Mar 31, 2024 | -1.99 Bn |
| Dec 31, 2023 | 2.08 Bn |
| Sep 30, 2023 | 2.08 Bn |
| Jun 30, 2023 | -1.91 Bn |
| Mar 31, 2023 | -2.70 Mn |
| Dec 31, 2022 | -3.49 Mn |
| Sep 30, 2022 | -7.18 Mn |
| Jun 30, 2022 | -4.56 Mn |
| Mar 31, 2022 | 1.99 Bn |
| Dec 31, 2021 | -1.92 Bn |
| Sep 30, 2021 | 1.52 Mn |